Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5429-5432

  Carpentier, Antoine F ^a,b   Chen, Lin ^c   Maltonti, Fabrice ^b   Delattre, Jean Yves ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGONUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER TRANSPLANTATION; IMMUNOREGULATION; MALE; MOUSE; NATURAL KILLER CELL; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CPG ISLANDS; IMMUNOHISTOCHEMISTRY; KILLER CELLS, NATURAL; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEUROBLASTOMA; OLIGODEOXYRIBONUCLEOTIDES; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0033230505     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bueler, H., and Mulligan, R. C. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mol. Med., 2: 545-555, 1996.
2. Syrengelas, A. D., Chen, T. T., and Levy, R. DNA immunization induces protective immunity against B-cell lymphoma. Nat. Med., 2: 1038-1041, 1996.
3. Bergman, I., Arbit, E., Rosenblum, M., Larson, S. M., Heller, G., and Cheung, N. K. Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8. J. Neurooncol., 15: 235-242, 1993.
4. Carpentier, A. F., Rosenfeld, M. R., Delattre, J. Y., Whalen, R. G., Posner, J. B., and Dalmau, J. DNA vaccination with HuD inhibits growth of a neuroblastoma in mice. Clin. Cancer Res., 4: 2819-2824, 1998.
5. Reynolds, J. V., Shou, J., Choi, H., Sigal, R., Ziegler, M. M., and Daly, J. M. The influence of natural killer cells in neuroblastoma. Arch. Surg., 124: 235-239, 1989.
6. Pession, A., Prete, A., Locatelli, F., Pierinelli, S., Pession, A. L., Maccario, R., Magrini, E., De Bemardi, B., Paolucci, P., and Paolucci, G. Immunotherapy with low-dose recombinant interleukin 2 after high-dose chemotherapy and autologous stem cell transplantation in neuroblastoma. Br. J. Cancer, 78: 528-533, 1998.
7. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., and Tokunaga, T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J. Immunol., 148: 4072-4076, 1992.
8. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., and Klinman, D. M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature (Lond.), 374: 546-549, 1995.
9. Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., and Cowdery, J. S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopathol., 84: 185-193, 1997.
10. Chu, R. S., Targoni, O. S., Krieg, A. M., Lehmann P. V., and Harding C. V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Thl) immunity. J. Exp. Med., 186: 1623-1631, 1997.
11. Roman, M., Martin-Orozco, E., Goodman, J. S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kombluth, R. S., Richman, D. D., Carson, D. A., and Raz, E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med., 3: 849-854, 1997.
12. Davis, H. L., Weeranta, R., Waldschmidt, T. J., Tygrett, L., Schorr, J., and Krieg, A. M. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol., 160: 870-876, 1998.
13. Seaman, W. E., Sleisenger, M., Eriksson, E., and Koo, G. C. Depletion of natural killer cells in mice by monoclonal antibody to NK-1.I. Reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol., 138: 4539-4544, 1987.
14. Ballas, Z. K., Rasmussen, W. L., and Krieg, A. M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol., 157: 1840-1845, 1996.
15. Boggs, R. T., McGraw, K., Condon, T., Flournoy, S., Villiet, P., Bennett, C. F., and Monia, B. P. Characterization and modulation of immune stimulation by modified oligonucleotides. Antisense Nucleic Acid Drug Dev., 7: 461-471, 1997.
16. Main, E. K., Lampson, L. A., Hart, M. K., Kornbluth, J., and Wilson, D. B. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes. J. Immunol., 135: 242-246, 1985.
17. Frey, A. B. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762. J. Immunol., 156: 3841-3849, 1996.
18. Bannerji, R., Arroyo, C. D., Cordon-Cardo, C., and Gilboa, E. The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity. J. Immunol., 152: 2324-2332, 1994.
19. Weiner, G. J., Liu, H. M., Wooldridge, J. E., Dahle, C. E., and Krieg, A. M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA, 94: 10833-10837, 1997.
20. Wooldridge, J. E., Ballas, Z., Krieg, A. M., and Weiner, G. J. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma. Blood, 89: 2994-2998, 1997.